PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 489.00
+1.50 (0.31%)
Nov 25, 2025, 12:35 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 180.3 billion as of November 24, 2025. Its market cap has decreased by -15.48% in one year.
Market Cap
180.30B
Enterprise Value
159.61B
Revenue
13.82B
Ranking
n/a
PE Ratio
37.65
Stock Price
489.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 180.30B, an increase of 357.80%. That is a compound annual growth rate of 13.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 180.30B | -11.93% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | 24.71B | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 213.25B |
| Lotus Pharmaceutical | 77.05B |
| Bora Pharmaceuticals Co., LTD. | 66.43B |
| Lumosa Therapeutics | 31.84B |
| Oneness Biotech | 29.03B |
| Lin BioScience | 28.54B |
| Center Laboratories | 27.36B |
| Pegavision | 24.02B |